Surgery after chemo for recurrent ovarian cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether removing recurrent ovarian cancer with surgery after chemotherapy can help patients live longer. It is for women whose cancer came back at least 6 months after finishing platinum-based chemo and who responded to chemo after the recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- Your ovarian, fallopian tube, or primary peritoneal cancer has come back for the first time.
- At least 6 months passed between your last platinum chemo and the cancer returning.
- Your cancer shrank or stayed stable after chemo for the recurrence.
- A surgeon believes the tumor can be completely removed.
- You have tumor tissue available for testing and agree to share your data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with recurrent ovarian cancer whose disease came back more than 6 months after platinum chemo. It tests whether removing the recurrent tumor with surgery (after more chemo) can help—even if surgery wasn't an option before.
This trial tests whether a second surgery to remove all visible cancer can help people with ovarian cancer that came back within 6 months of finishing platinum chemotherapy. The goal is to see if this surgery improves outcomes compared with standard care.
This trial tests whether doing additional surgery to remove visible tumor (“secondary cytoreduction”) before chemotherapy helps compared with chemotherapy alone. It’s for ovarian (or related) cancer that came back after prior PARP inhibitor maintenance and platinum chemotherapy.
This trial tests whether having a second surgery after initial treatment can help people with ovarian cancer that came back but still responds to platinum-based chemotherapy. It may offer another option to remove remaining tumors and delay further treatments.
This trial tests if laparoscopic surgery after 3-4 cycles of chemotherapy can help people with advanced epithelial ovarian cancer. It's for those whose tumors have shrunk enough after chemo and who are healthy enough for surgery.
This trial tests whether doing additional (“secondary”) tumor-removal surgery can help people with ovarian, fallopian tube, or primary peritoneal cancer that has returned after PARP inhibitor maintenance. It focuses on people whose cancer can likely be fully removed and who are considered good candidates for surgery and follow-up treatment.
Hear when a new Platinum-sensitive Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.